China Vascular Grafts Market is expected to expand at a CAGR of 8.6% from 2021 to 2028
China Vascular Grafts Industry Overview The China vascular grafts market size was valued at USD 91.0 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.6% from 2021 to 2028. Increasing incidence of various health conditions or diseases, which can damage the aorta and pose a life-threatening risk, is a major factor aiding the adoption of cost-effective vascular grafts in China. Health conditions that were considered are hypertension, injury atherosclerosis, Marfan syndrome, and connective tissue disorders, like polychondritis, osteogenesis imperfecta, scleroderma, Ehlers -Danlos disorder, Turner syndrome, and polycystic kidney disease. In addition, the rising need for early detection and prevention of coronary heart disease has led to an increase in the number of treatment options such as bypass grafting operations and treatment interventions. The presence of a large population is expected to increase the demand for stent-graf...